Long-Term Outcomes after Abdominal Wall Reconstruction with Acellular Dermal Matrix
Background Long-term outcomes data for hernia recurrence rates after abdominal wall reconstruction (AWR) with acellular dermal matrix (ADM) are lacking. The aim of this study was to assess the long-term durability of AWR using ADM. Study Design We studied patients who underwent AWR with ADM at a sin...
Saved in:
Published in | Journal of the American College of Surgeons Vol. 224; no. 3; pp. 341 - 350 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.03.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background Long-term outcomes data for hernia recurrence rates after abdominal wall reconstruction (AWR) with acellular dermal matrix (ADM) are lacking. The aim of this study was to assess the long-term durability of AWR using ADM. Study Design We studied patients who underwent AWR with ADM at a single center in 2005 to 2015 with a minimum follow-up of 36 months. Hernia recurrence was the primary end point and surgical site occurrence (SSO) was a secondary end point. The recurrence-free survival curves were estimated by Kaplan-Meier product limit method. Univariate and multivariable Cox proportional hazards regression models and logistic regression models were used to evaluate the associations of risk factors at surgery with subsequent risks for hernia recurrence and SSO, respectively. Results A total of 512 patients underwent AWR with ADM. After excluding those with follow-up less than 36 months, 191 patients were included, with a median follow-up of 52.9 months (range 36 to 104 months). Twenty-six of 191 patients had a hernia recurrence documented in the study. The cumulative recurrence rates were 11.5% at 3 years and 14.6% by 5 years. Factors significantly predictive of hernia recurrence developing included bridged repair, wound skin dehiscence, use of human cadaveric ADM, and coronary disease; component separation was protective. In a subset analysis excluding bridged repairs and human cadaveric ADM patients, cumulative hernia recurrence rates were 6.4% by 3 years and 8.3% by 5 years. The crude rate of SSO was 25.1% (48 of 191). Factors significantly predictive of the incidence of SSO included at least 1 comorbidity, BMI ≥30 kg/m2 , and defect width >15 cm. Conclusions Use of ADM for AWR was associated with 11.5% and 14.6% hernia recurrence rates at 3- and 5-years follow-up, respectively. Avoiding bridged repairs and human cadaveric ADM can improve long-term AWR outcomes using ADM. |
---|---|
AbstractList | BACKGROUNDLong-term outcomes data for hernia recurrence rates after abdominal wall reconstruction (AWR) with acellular dermal matrix (ADM) are lacking. The aim of this study was to assess the long-term durability of AWR using ADM.STUDY DESIGNWe studied patients who underwent AWR with ADM at a single center in 2005 to 2015 with a minimum follow-up of 36 months. Hernia recurrence was the primary end point and surgical site occurrence (SSO) was a secondary end point. The recurrence-free survival curves were estimated by Kaplan-Meier product limit method. Univariate and multivariable Cox proportional hazards regression models and logistic regression models were used to evaluate the associations of risk factors at surgery with subsequent risks for hernia recurrence and SSO, respectively.RESULTSA total of 512 patients underwent AWR with ADM. After excluding those with follow-up less than 36 months, 191 patients were included, with a median follow-up of 52.9 months (range 36 to 104 months). Twenty-six of 191 patients had a hernia recurrence documented in the study. The cumulative recurrence rates were 11.5% at 3 years and 14.6% by 5 years. Factors significantly predictive of hernia recurrence developing included bridged repair, wound skin dehiscence, use of human cadaveric ADM, and coronary disease; component separation was protective. In a subset analysis excluding bridged repairs and human cadaveric ADM patients, cumulative hernia recurrence rates were 6.4% by 3 years and 8.3% by 5 years. The crude rate of SSO was 25.1% (48 of 191). Factors significantly predictive of the incidence of SSO included at least 1 comorbidity, BMI ≥30 kg/m2, and defect width >15 cm.CONCLUSIONSUse of ADM for AWR was associated with 11.5% and 14.6% hernia recurrence rates at 3- and 5-years follow-up, respectively. Avoiding bridged repairs and human cadaveric ADM can improve long-term AWR outcomes using ADM. Background Long-term outcomes data for hernia recurrence rates after abdominal wall reconstruction (AWR) with acellular dermal matrix (ADM) are lacking. The aim of this study was to assess the long-term durability of AWR using ADM. Study Design We studied patients who underwent AWR with ADM at a single center in 2005 to 2015 with a minimum follow-up of 36 months. Hernia recurrence was the primary end point and surgical site occurrence (SSO) was a secondary end point. The recurrence-free survival curves were estimated by Kaplan-Meier product limit method. Univariate and multivariable Cox proportional hazards regression models and logistic regression models were used to evaluate the associations of risk factors at surgery with subsequent risks for hernia recurrence and SSO, respectively. Results A total of 512 patients underwent AWR with ADM. After excluding those with follow-up less than 36 months, 191 patients were included, with a median follow-up of 52.9 months (range 36 to 104 months). Twenty-six of 191 patients had a hernia recurrence documented in the study. The cumulative recurrence rates were 11.5% at 3 years and 14.6% by 5 years. Factors significantly predictive of hernia recurrence developing included bridged repair, wound skin dehiscence, use of human cadaveric ADM, and coronary disease; component separation was protective. In a subset analysis excluding bridged repairs and human cadaveric ADM patients, cumulative hernia recurrence rates were 6.4% by 3 years and 8.3% by 5 years. The crude rate of SSO was 25.1% (48 of 191). Factors significantly predictive of the incidence of SSO included at least 1 comorbidity, BMI ≥30 kg/m2 , and defect width >15 cm. Conclusions Use of ADM for AWR was associated with 11.5% and 14.6% hernia recurrence rates at 3- and 5-years follow-up, respectively. Avoiding bridged repairs and human cadaveric ADM can improve long-term AWR outcomes using ADM. Long-term outcomes data for hernia recurrence rates after abdominal wall reconstruction (AWR) with acellular dermal matrix (ADM) are lacking. The aim of this study was to assess the long-term durability of AWR using ADM. We studied patients who underwent AWR with ADM at a single center in 2005 to 2015 with a minimum follow-up of 36 months. Hernia recurrence was the primary end point and surgical site occurrence (SSO) was a secondary end point. The recurrence-free survival curves were estimated by Kaplan-Meier product limit method. Univariate and multivariable Cox proportional hazards regression models and logistic regression models were used to evaluate the associations of risk factors at surgery with subsequent risks for hernia recurrence and SSO, respectively. A total of 512 patients underwent AWR with ADM. After excluding those with follow-up less than 36 months, 191 patients were included, with a median follow-up of 52.9 months (range 36 to 104 months). Twenty-six of 191 patients had a hernia recurrence documented in the study. The cumulative recurrence rates were 11.5% at 3 years and 14.6% by 5 years. Factors significantly predictive of hernia recurrence developing included bridged repair, wound skin dehiscence, use of human cadaveric ADM, and coronary disease; component separation was protective. In a subset analysis excluding bridged repairs and human cadaveric ADM patients, cumulative hernia recurrence rates were 6.4% by 3 years and 8.3% by 5 years. The crude rate of SSO was 25.1% (48 of 191). Factors significantly predictive of the incidence of SSO included at least 1 comorbidity, BMI ≥30 kg/m , and defect width >15 cm. Use of ADM for AWR was associated with 11.5% and 14.6% hernia recurrence rates at 3- and 5-years follow-up, respectively. Avoiding bridged repairs and human cadaveric ADM can improve long-term AWR outcomes using ADM. |
Author | Baumann, Donald P., MD, FACS Butler, Charles E., MD, FACS Giordano, Salvatore A., MD, PhD Liu, Jun, PhD Garvey, Patrick B., MD, FACS |
Author_xml | – sequence: 1 fullname: Garvey, Patrick B., MD, FACS – sequence: 2 fullname: Giordano, Salvatore A., MD, PhD – sequence: 3 fullname: Baumann, Donald P., MD, FACS – sequence: 4 fullname: Liu, Jun, PhD – sequence: 5 fullname: Butler, Charles E., MD, FACS |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27993696$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkU1P3DAQhi1EBSzwF1B66yWpx9nY8aXSin6AtAiJ3apHy_FOwMGJqZ205d_X0QLiZMt-Zvz6mQU5HPyAhHwEWgAF_rkrOt0b71ycwn3B0lEBUFAQB-QEaiFzAEkP054KlosKqmOyiLGjiaCSH5FjJqQsueQnZLP2w32-xdBnt9NofI8x0-2IIVs1O9_bQbvsl3Yuu0PjhziGyYzWD9lfOz5kK4POTU6H7GtqkMgbPQb774x8aLWLeP6ynpKf379tL6_y9e2P68vVOjelYGO-E6xtUlApNeyEgLJiSAXWLZdLKtMV1rxqq0agZKZhSyFkw_nSgMayNdSUp-TTvu9T8L8njKPqbZwj6QH9FBXUFZSUSVEnVO5RE3yMAVv1FGyvw7MCqmanqlPvnKrZqQJQyViqvXh5Zmp63L1VvkpMwJc9gOmzfywGZZwdrNHuEZ8xdn4KSWPKoyJTVG3mscxTAV4Cl5Uo_wMAWY3M |
CitedBy_id | crossref_primary_10_1080_23320885_2023_2285054 crossref_primary_10_1016_j_amjsurg_2018_01_072 crossref_primary_10_1007_s10029_018_1799_8 crossref_primary_10_1021_acssuschemeng_1c06941 crossref_primary_10_1097_SLA_0000000000004454 crossref_primary_10_3390_polym13121928 crossref_primary_10_1007_s40137_020_00272_4 crossref_primary_10_1097_XCS_0000000000000141 crossref_primary_10_1186_s42825_022_00093_4 crossref_primary_10_1097_SAP_0000000000002201 crossref_primary_10_1097_PRS_0000000000010292 crossref_primary_10_1016_j_suc_2018_02_006 crossref_primary_10_1016_j_jss_2020_05_060 crossref_primary_10_1093_jscr_rjy345 crossref_primary_10_3390_jcm10214998 crossref_primary_10_1007_s10029_018_1738_8 crossref_primary_10_1097_PRS_0000000000004854 crossref_primary_10_1016_j_msec_2020_111645 crossref_primary_10_2147_TCRM_S410574 crossref_primary_10_3390_traumacare4020012 crossref_primary_10_1007_s10029_022_02731_6 crossref_primary_10_1097_PRS_0000000000004859 crossref_primary_10_1177_20595131211038313 crossref_primary_10_22730_jmls_2021_18_3_56 crossref_primary_10_1088_1748_605X_ab0355 crossref_primary_10_1097_GOX_0000000000004709 crossref_primary_10_1097_PRS_0000000000004862 crossref_primary_10_1016_j_tice_2021_101572 crossref_primary_10_3389_frtra_2023_1133806 crossref_primary_10_1016_j_biomaterials_2018_03_049 crossref_primary_10_1097_PRS_0000000000003976 crossref_primary_10_1097_PRS_0000000000004867 crossref_primary_10_1111_ans_19153 crossref_primary_10_1007_s00268_023_07154_7 crossref_primary_10_1016_j_ijsu_2019_12_035 crossref_primary_10_1097_PRS_0000000000010810 crossref_primary_10_1007_s00268_018_4765_9 crossref_primary_10_1007_s00268_020_05887_3 crossref_primary_10_1007_s00464_019_07012_5 crossref_primary_10_1097_PRS_0000000000008669 crossref_primary_10_1002_bjs5_78 crossref_primary_10_1097_PRS_0000000000004860 crossref_primary_10_1016_j_amjsurg_2021_05_019 crossref_primary_10_1016_j_bjps_2020_10_005 crossref_primary_10_12968_hmed_2018_0428b crossref_primary_10_1016_j_ijsu_2017_05_031 crossref_primary_10_1097_AS9_0000000000000032 crossref_primary_10_1097_AS9_0000000000000152 crossref_primary_10_1001_jamanetworkopen_2022_12444 crossref_primary_10_1245_s10434_023_13098_y crossref_primary_10_1097_SAP_0000000000001692 crossref_primary_10_1016_j_mtbio_2023_100691 crossref_primary_10_1007_s10029_019_02119_z crossref_primary_10_1097_GOX_0000000000002635 crossref_primary_10_1177_00031348221093804 crossref_primary_10_1002_star_201700319 crossref_primary_10_3390_jcm11206035 crossref_primary_10_1093_asj_sjz208 crossref_primary_10_1155_2020_3475289 |
ContentType | Journal Article |
Copyright | American College of Surgeons Copyright © 2016 American College of Surgeons. Published by Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: American College of Surgeons – notice: Copyright © 2016 American College of Surgeons. Published by Elsevier Inc. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.jamcollsurg.2016.11.017 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1879-1190 |
EndPage | 350 |
ExternalDocumentID | 10_1016_j_jamcollsurg_2016_11_017 27993696 1_s2_0_S1072751516316957 |
Genre | Journal Article |
GroupedDBID | - 08R 0R 1 1- 1B1 1KJ 1P 1~. 1~5 29L 2QL 3O- 4.4 457 4G. 53G 55 5GY 5RE 5VS 6PF 7-5 71M 8P AABNK AACTN AAEDT AAGIX AAIAV AAIKJ AAJCS AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AAWTL AAXUO ABBQC ABFLS ABFRF ABLVK ABMAC ABMZM ABOCM ABPPZ ABPTK ABQIS ABWYI ABXDB ABYKQ ACBMB ACDAQ ACGFO ACGFS ACIUM ACRLP ADALY ADBBV ADEZE AEBDS AEFWE AEKER AENEX AEVXI AFCTW AFFNX AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AI. AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EJD EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU G- GBLVA GJ HVGLF HZ IH2 IHE IPNFZ J1W J5H K KOM L7B LCYCR LXL LXN M M41 MO0 N4W N9A O-L O9- OAUVE OHT OVD OZT P-8 P-9 P2P PC. PQEST PQQKQ Q38 R2- RIG ROL RPZ RU SDF SDG SEL SES SEW SJN SPCBC SSH SSZ T5K TEORI UHB UV1 UXK VH1 WH7 WOW X7M ZA5 ZGI ZRR ZXP --- --K --M -RU .55 .GJ .~1 0R~ 1CY 1P~ 8P~ AAAAV AAEDW AAIQE AAQOH ABJNI ACILI ACXJB ADMUD AFEXH AHOMT AHQNM AJNWD AJZMW AKRWK CGR CUY CVF ECM EEVPB EIF ERAAH FCALG HZ~ NPM RLZ ~G- AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c372t-d72fb19099a1d771352e07e8f69409fb1e865f5b7e92cb24779b664c1ae3fc0c3 |
ISSN | 1072-7515 |
IngestDate | Sat Aug 17 02:07:55 EDT 2024 Fri Aug 23 02:57:20 EDT 2024 Sat Sep 28 08:00:20 EDT 2024 Thu Aug 18 17:15:22 EDT 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | CS abdominal wall reconstruction OR surgical site occurrence component separation hazard ratio ADM acellular dermal matrix HR odds ratio AWR SSO |
Language | English |
License | Copyright © 2016 American College of Surgeons. Published by Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c372t-d72fb19099a1d771352e07e8f69409fb1e865f5b7e92cb24779b664c1ae3fc0c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 27993696 |
PQID | 1851302978 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1851302978 crossref_primary_10_1016_j_jamcollsurg_2016_11_017 pubmed_primary_27993696 elsevier_clinicalkeyesjournals_1_s2_0_S1072751516316957 |
PublicationCentury | 2000 |
PublicationDate | 2017-03-01 |
PublicationDateYYYYMMDD | 2017-03-01 |
PublicationDate_xml | – month: 03 year: 2017 text: 2017-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of the American College of Surgeons |
PublicationTitleAlternate | J Am Coll Surg |
PublicationYear | 2017 |
SSID | ssj0017096 |
Score | 2.4968677 |
Snippet | Background Long-term outcomes data for hernia recurrence rates after abdominal wall reconstruction (AWR) with acellular dermal matrix (ADM) are lacking. The... Long-term outcomes data for hernia recurrence rates after abdominal wall reconstruction (AWR) with acellular dermal matrix (ADM) are lacking. The aim of this... BACKGROUNDLong-term outcomes data for hernia recurrence rates after abdominal wall reconstruction (AWR) with acellular dermal matrix (ADM) are lacking. The aim... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 341 |
SubjectTerms | Abdominal Wall - surgery Abdominal Wound Closure Techniques Acellular Dermis Adult Aged Female Hernia, Ventral - surgery Herniorrhaphy Humans Logistic Models Male Middle Aged Proportional Hazards Models Recurrence Retrospective Studies Surgery Surgical Mesh Time Factors Treatment Outcome |
Title | Long-Term Outcomes after Abdominal Wall Reconstruction with Acellular Dermal Matrix |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S1072751516316957 https://www.ncbi.nlm.nih.gov/pubmed/27993696 https://search.proquest.com/docview/1851302978 |
Volume | 224 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9QwFA7jCuKLKN7GG1nwrbSkSdu0j7NeWGRXhZmFfQtJm8rOrh2xMyI--Fv8qZ7TtJmuOqj7UoaGZtJ8X05yTs-FkOeCVZabVIRJXqRhonMRGlbXoPPEWZWWtdRdhPfx2-zwJHlzmp5OJj9GXkubtYnKb3-MK7kKqnAPcMUo2f9A1ncKN-A34AtXQBiu_4Tx0ar5EC5AtgbvNmv4A9v2Nb9nplq5al3dp2fUMbeZYp3tdYYm-84H9SUK54vgGJP1f91xWB0FoDRjY8Mco6oHix-68ejPfYVll_v_PDiIfNsZKLq6K_UdzPXFF1T3oVfffqDxg4KTgp3FOnjv247ONi6GpBmbKWDr835avWRlEo7yqYvdHEQvd_HTPcfESJAKlw6r35OFS077m7h3lodltNQfcdm08M7orZdFmJjVxYReTrH9y9bnHRIHX7elGnWlsCtQkRR0dY1c57JIUb2PvnsnoliyrgKcf7kbZH_rQbhjVLtOQLs0nO6ks7hNbvWo05nj2x0ysc1dMvdcowPXaMc16rlGkWv0Mtcoco16rlHHNeq4do-cvH61eHEY9gU5wlJIvg4ryWsDJ8ii0HElsbgjt0zavM6KhBXQZPMsrVMjbcFLwxMpC5NlSRlrK-qSleI-2WtWjX1IqGZJbISRUudZwnSV80LbSoDyXjELszolfJgk9cnlXVF_BWlK5DCdaggshq3Qtv2abVWsWq6YmiNgiBdoI3EGsE7J_jD7CuQrzopu7GoDT4BKIrDCWz4lDxwsfkDAiK4e5qOrDPYxubldJ0_IHgBjn8IBd22edRz7CaIqqHU |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-Term+Outcomes+after+Abdominal+Wall+Reconstruction+with+Acellular+Dermal+Matrix&rft.jtitle=Journal+of+the+American+College+of+Surgeons&rft.au=Garvey%2C+Patrick+B.&rft.au=Giordano%2C+Salvatore+A.&rft.au=Baumann%2C+Donald+P.&rft.au=Liu%2C+Jun&rft.date=2017-03-01&rft.issn=1072-7515&rft.volume=224&rft.issue=3&rft.spage=341&rft.epage=350&rft_id=info:doi/10.1016%2Fj.jamcollsurg.2016.11.017&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jamcollsurg_2016_11_017 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1072-7515&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1072-7515&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1072-7515&client=summon |